Skip to main content
. Author manuscript; available in PMC: 2019 Mar 1.
Published in final edited form as: J Thorac Cardiovasc Surg. 2017 Nov 13;155(3):1212–1224.e3. doi: 10.1016/j.jtcvs.2017.09.151

Appendix Table 2.

Multivariable Complete Case Analysis (N=622)

Variable Distant Recurrence Any Recurrence
HR (95% CI) p-value HR (95% CI) p-value
Age 1.01 (0.99–1.04) 0.326 1.02 (0.99–1.04) 0.215
Tumor SUV 1.04 (0.99–1.10) 0.107 1.04 (0.98–1.09) 0.177
Time of Surgery (Tertile)
 2000–2006 1.00 - 1.00 -
 2007–2013 0.68 (0.38–1.24) 0.212 0.71 (0.40–1.25) 0.235
 2014–2016 0.46 (0.19–1.08) 0.074 0.46 (0.20–1.05) 0.065
Histologic Subtype
 Lepidic 1.00 - 1.00 -
 Acinar 2.11 (0.63–7.07) 0.228 1.48 (0.53–4.15) 0.453
 Papillary 1.95 (0.53–7.25) 0.317 1.76 (0.58–5.31) 0.317
 Micropapillary 4.48 (1.06–19.0) 0.042 3.38 (0.97–11.7) 0.056
 Solid 3.20 (0.88–11.6) 0.078 2.18 (0.70–6.84) 0.180
 Other 4.70 (0.84–26.4) 0.079 2.91 (0.57–14.9) 0.201
Lymphovascular Invasion
 Absent 1.00 - 1.00 -
 Present 1.26 (0.71–2.27) 0.432 1.49 (0.86–2.58) 0.154
pT stage
 1a 1.00 - 1.00 -
 1b 2.07 (0.91–4.72) 0.084 2.13 (0.98–4.61) 0.055
 2a 3.25 (1.55–6.83) 0.002 3.25 (1.60–6.58) 0.001
 2b/3 6.43 (2.40–17.3) <0.001 7.86 (3.09–20.0) <0.001